Lilly JVBA

A Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab vs Docetaxel and Placebo in Treatment of Stage IV Non-Small Cell Lung Cancer Following Disease Progression After One Prior Platinum-Based Therapy.

Lilly JDCG

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Tabalumab in Combination with Bortezomib and Dexamethasone in Patients with Previously Treated Multiple Myeloma.


A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study of Sativex oromucosal spray (Sativex, Nabiximols) as Adjunctive Therapy in Relieving Uncontrolled Persistent Chronic Pain in Patients with Advanced Cancer, Who Experience Inadequate Analgesia During...

APPA C2013-01

A Prospective, Randomized, Placebo-Controlled, Double-Blind, Multi-Center, Phase 3 Study of APF530 500mg SC, Fosprepitant 150mg IV, and Dexamethasone vs Ondansetron 0.15mg/kg IV, Fosaprepitant 150mg IV, and Dexamethasone for the Prevention of Chemotherapy-Induced...

BI 1302.5

A multicenter, randomized, double-blind Phase III trial to evaluate efficacy and safety of BI 695502 plus chemotherapy versus Avastin® plus chemotherapy in patients with advanced nonsquamous Non-Small Cell Lung Cancer